Blue Horseshoe Stocks: More SPY Action

SPDRA S&P 500 ETF (SPY)

We want to formulate a new options idea for the SPY, but first, we would like to present the final performance of the Weekly SPY Calls we signaled last Tuesday.

Those were the SPY Weekly SPY Weekly $272.50-274 Calls and the gains they experienced over the course of the short holiday week were exceedingly impressive, with percentage increases in the thousands on two out of four contracts, with the other two set not trailing far behind, with huge multi-bag gains of their own. .

$272.50 Calls – Range: .43-3.35 – Max Gain: 679%
$273 Calls – Range: .28-2.82 – Max Gain: 907%
$273.50 Calls – Range: 17-2.35 – Max Gain: 1282%
$274 Calls – Range: .09-1.82 – Max Gain: 1922%

As we mentioned above, we’ve got a fresh idea for the SPY for today as well. in the wake of this morning’s positive jobs numbers. We’re going to keep an eye on the SPY 07/09 (Expire Today*) 275.50-277 Calls.

*Speculation in these contracts today is tantamount to trading weekly options on a Friday. Should NOT be attempted, except by veteran traders with disposal funds!


Intrexon Corp. XON – Form-4 Bottom Bouncer

We’re very interested in the current scenario with XON. We noticed the CEO purchasing roughly $100M worth of the company’s stock last week at 13.37, and we like the current technical setup as well, with a strong bottom bounce in progress along with a gap on the chart to the upside.

We could see an significant move happening for the stock itself, but we also want to include an extended term options idea for more leverage in the case of a protracted recovery, which is presently looking like a solid possibility. We’ll have an eye on the XON 08/17 $14-17 Calls.


Extended Watchlist:
BIOAQ, PVG, SECO, RIOT, LEDS, ASTC, RIBT

Blue Horseshoe Stocks: BABA Review & More

Alibaba Group Holding Ltd. BABA – Update

After noticing a strong double-bottom setup on the chart, we threw our hat in the ring with BABA yesterday morning by formulating an options idea to track during what we described as an overdue recovery.

The stock did exhibit the first signs of that recovery, thereby producing some nice single-session gain opportunities for ourselves and our readers. Our targeted options were the BABA 05/04 $180-187.50 Calls, and regardless of the strike price chosen within our designated range, notable able intraday profits were there for the taking.

$180 Calls – Range: 3.60-5.10  – Max Gain: 42%
$182.50 Calls – Range: 2.80-3.75 – Max Gain: 34%
$185 Calls – Range: 2.21-3.05 – Max Gain: 38%
$187.50 Calls – Range: 1.74-2.27 – Max Gain: 30%

There is, of course, plenty of time before these contracts expire, so we’ll continue monitor these ideas going forward in the event that BABA stock continues its rebounding ways. Further opportunities may arise and we’ll want to be ready.


Tandem Diabetes Care, Inc. TNDM – Update

We also wanted to update everyone on another longer term idea we formulated that has definitely worked out in our favor. We’ve had a number of stocks that we signaled our interest in earlier in 2018 slowly and steadily make monster moves for us, and TNDM is the latest one.

We initially slated this play for observation In mid-January, and after only a slight consolidation at the beginning of February, the stock established support at a low of 2.14, reversed, and began a really impressive bull run that was amplified by a significant degree yesterday. TNDM ran to a new high of 7.22. That works out to a 237% increase here in the early goings of the 2018 calendar year.


Extended Watchlist:
PVG, CRIS, EYEG, CBAY, PRPO

Blue Horseshoe: The Week in Review

For as long as we can remember following the Penny Stock Rumble, we can’t recall a time when a newsletter took the top spot on 3 out of 4 days, but with yesterday’s session, we did in fact reach that difficult achievement! We were anticipating our first ever hat-trick, and we were not disappointed. The following video outlines some of this week’s biggest successes:

Tiger Oil & Energy, Inc. TGRO

We started off Monday with TGRO, which traded as low as .36, and hit .635 on Tuesday for a 76% gain. It would then dip back to .38 before reversing again and surging as high as .62 yesterday for up to 63% on the rebound.

That brought this week’s cumulative gains from TGRO to a total of 139%.


BG Medicine, Inc. BGMD

Next came BGMD, which we spotted on Tuesday trading as low as .6115. We would witness this play running to a high of 1.70 by Wednesday, giving us the opportunity at 178% in possible gains.


CytRx Corp. CYTR

Last but not least, was Wednesday’s alert of CYTR, which looks like it could sprout legs again today. CYTR was as low as 3.45 at the time of our initial alert, and hit a high of 6.36 yesterday, racking in 84% in gains!

This morning, CYTR is gapping up once again, trading in the 6.55 range; if the breakout continues, consider it another triple-digit winner for us.

This was the play that gave us our third winning appearance on the Rumble:


Coronado BioSciences, Inc. CNDO

CNDO jumped out at us as a stock with a serious gap to fill on the chart. As you can see below, back in October the stock fell off a cliff from the $6-8 range all the way down to present levels.

This is a potential play that we’ll want to monitor closely moving forward, because a break of the 50DMA could very well lead to the filling of at least a portion of that gap, a move which would carry with it some significant gains.


With calls like these this week, we’ve made other newsletters obsolete! Nowhere else can you find both diversification into many areas of finance(from microcaps, to big-boards, to options-trading & more), and winning picks on such a consistent basis. Why would you go anywhere else? The word ‘quit’ is not in our vocabulary, which is why we’ll come back time and time again, providing our readers with the highest-quality picks available! We’re wrapping up another hugely successful week, so be sure to get back with us on Monday when we’ll do it all over again!


Extended Watchlist:
SFBR, PLUG, MACK, CLSN, ICLD, PVG, PTIX, ETAK